The therapy, EPI-321, is intended to treat cases of facioscapulohumeral muscular dystrophy, a genetic neuromuscular disorder.

After trying reformer pilates for one month, I discovered remarkable benefits including increased strength, improved posture, ...

Although measles is seen as a contagious viral disease that passes quickly, it can also cause damage that leaves long-term health effects. A measles infection can lead to a phenomenon called 'immune ...

Yoda Therapeutics Inc. (YODA), an AI-driven company that focuses on Central Nervous System (CNS) drugs, today announced the dosing of the first patient in the Phase 2 trial of YA-101 for Multiple ...

The U.S. Food and Drug Administration (FDA) has approved a new class of antibiotics for treating uncomplicated urinary tract ...

The SMART Broiler program was started in 2019, as FFAR and McDonald’s kicked off a public-private partnership with an investment of $4 million to utilize two phases of research grants focused on ...

The US Food and Drug Administration (FDA) is evaluating under priority review the regulatory submission of tolebrutinib to treat non-relapsing secondary progressive multiple sclerosis (nrSPMS) and to ...

Tolebrutinib regulatory submission accepted for priority review in the US for patients with multiple sclerosisIf approved, tolebrutinib would be ...

The Dnsys X1 is a lower-body "AI-powered" exoskeleton that’s designed to make movement easier on your leg muscles, joints and ...

Augustine Therapeutics has raised €78 million ($85 million) in first-round funding for a pipeline headed by a candidate for ...

Tolebrutinib is currently under clinical investigation, and its safety and efficacy have not been evaluated by any regulatory ...

The paper aeroplanes were back. As was the Mexican wave. In many ways this was a same-old, same-old Wembley performance from ...